Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Lijiang ChenDianrui Zhang

Abstract

Bexarotene (Targretin®) is a synthetic retinoid that selectively activates the retinoid X receptor subfamily of retinoid receptors and exhibits potent anti-tumor activity. However, the poor solubility and bioavailability limit its application. The main aim of this study is to investigate the potential of oral and parenteral nanocrystals in enhancing the bioavailability of bexarotene. In this work, the orthogonal design was used to screen the optimum stabilizers and precipitation-combined microfluidization method was employed to obtain the optimal nanocrystals. According to DSC, X-ray diffraction analysis and Raman examination, the nanocrystals were still in crystalline state after the preparation procedure. By reducing the particle size, the in vitro dissolution rate of bexarotene was increased significantly. The in vivo test was carried out in rats and pharmacokinetic parameters of the bexarotene solution and bexarotene nanocrystals were compared after gavage and intravenous administration. The higher AUC and lower Cmax indicated that oral bexarotene nanocrystals significantly increased the bioavailability of bexarotene and decreased its side effects. Compared to the oral nanocrystals, the intravenous nanocrystals cut losses a...Continue Reading

References

Jul 2, 1998·Journal of Pharmaceutical Sciences·S H YalkowskyG H Ward
Sep 2, 2004·Nature Reviews. Drug Discovery·Barrett E Rabinow
Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wan-Ching YenWilliam W Lamph
Jul 5, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Thomas W HermannReid P Bissonnette
Sep 1, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Cornelia M Keck, Rainer H Müller
Jan 24, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Matthew Todd CrispKeith P Johnston
Mar 27, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Kalle SigfridssonJennie de Verdier
Jul 3, 2007·Advanced Drug Delivery Reviews·Filippos KesisoglouYunhui Wu
Aug 11, 2007·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Sébastien BranchuWalter G Cook
Aug 30, 2008·International Journal of Pharmaceutics·Bernard Van EerdenbrughPatrick Augustijns
Nov 11, 2008·International Journal of Nanomedicine·Jens-Uwe A H Junghanns, Rainer H Müller
Jul 15, 2009·International Journal of Pharmaceutics·Sudhir VermaDiane J Burgess
Oct 24, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Gregor Cevc, Ulrich Vierl
Mar 9, 2010·Drug Discovery Today·Huabing ChenJinming Gao
Aug 10, 2010·Nanomedicine : Nanotechnology, Biology, and Medicine·Swarnali Das, Preeti K Suresh
Sep 9, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Richard HardingIrene J Higginson
Oct 16, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hany S M AliNicholas Blagden
Nov 10, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Wilson H RoaRaimar Löbenberg
Nov 26, 2010·International Journal of Pharmaceutics·Lei GaoJing Ma
Nov 30, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Reinhard H H Neubert
Dec 2, 2010·Advanced Drug Delivery Reviews·Jian ZhangWiwik Watanabe
Dec 24, 2010·Colloids and Surfaces. B, Biointerfaces·Yancai WangQiang Zhang
Dec 28, 2010·International Journal of Pharmaceutics·Sudhir VermaDiane J Burgess
Jan 27, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Rainer H MüllerCornelia M Keck
Feb 5, 2011·Current Drug Discovery Technologies·Rainer H MüllerCornelia M Keck
Feb 15, 2011·Advanced Drug Delivery Reviews·Libo WuWiwik Watanabe
Jun 18, 2011·Veterinary Parasitology·Juan M IracheSocorro Espuelas
Aug 16, 2011·Nanomedicine : Nanotechnology, Biology, and Medicine·Wei SunLiang Fang
Sep 1, 2011·International Journal of Pharmaceutics·Jianjun ZhangYuan Gao
Sep 8, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Mitali KakranRainer H Müller
Oct 1, 2011·Drug Discovery Today·Murali M YallapuSubhash C Chauhan
Oct 6, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·R H Müller, C M Keck
Oct 18, 2011·Clinical Lymphoma, Myeloma & Leukemia·Neha MehtaSteven Horwitz
Nov 29, 2011·International Journal of Pharmaceutics·Guangpu LiuHongxiang Lou
Dec 27, 2011·Journal of Biomedical Nanotechnology·Yue LiuQiang Zhang
Jan 12, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jaime SalazarJan P Möschwitzer
Jan 25, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Michael JuhnkeEdgar John
Feb 22, 2012·Chemistry and Physics of Lipids·Anna ElgartAmnon Hoffman
Apr 3, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lei GaoXiang Li
May 15, 2012·International Journal of Pharmaceutics·Leilei HaoQiang Zhang

❮ Previous
Next ❯

Citations

May 31, 2014·Neurobiology of Disease·Rebecca SkerrettGary Landreth
Dec 10, 2014·International Journal of Pharmaceutics·Bhupesh K AhujaSarasija Suresh
Sep 3, 2016·Drug Development and Industrial Pharmacy·Yongjie WangLijiang Chen
Feb 17, 2017·Scientific Reports·M M MarianiG E Landreth
Oct 19, 2017·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Xiaoqing MiaoPeng Huang
Aug 15, 2019·Nanomedicine·Francisco ArriagadaJavier Morales
Feb 2, 2019·Current Pharmaceutical Design·Mamunur RashidMuhammad Wahajuddin
Feb 15, 2017·Drug Delivery and Translational Research·Sandeep K SinghJiaur R Gayen
Sep 25, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Dongrui LiangAiping Lu
Dec 21, 2014·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Lisi QiYuxia Luan
Aug 24, 2018·Pharmaceutics·Maria Rosa GigliobiancoPiera Di Martino
Jul 3, 2020·Drug Delivery and Translational Research·Edilson Ribeiro de Oliveira JuniorEliana Martins Lima
May 13, 2020·Current Drug Delivery·Mori DhavalKiran Dudhat
Nov 22, 2020·International Immunopharmacology·Yongjie WangDeqing Sun
May 16, 2020·Materials Science & Engineering. C, Materials for Biological Applications·Katherine Jasmine Curo MeloNádia Araci Bou-Chacra
Mar 9, 2021·AAPS PharmSciTech·Shabari Girinath Kala, Santhivardhan Chinni
May 17, 2021·International Journal of Pharmaceutics·Vivek VermaLuis Padrela

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.